Sign In
Buy KALA
$3.54
-0.0700 (-1.94%)
At Close: Jun 22, 2026
Why Kala Pharmaceuticals Shares Are Rising Today
10:17am, Monday, 23'rd May 2022
Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS treatments for $60 million. Kala Pharmaceuticals is selling its commerci
Penny Stocks To Buy Now? 4 To Watch Under $1
09:34am, Monday, 23'rd May 2022
Penny stocks under $1 to watch right now. The post Penny Stocks To Buy Now?
Kala Announces Entry into Definitive Agreement to Sell EYSUVIS® and INVELTYS® to Alcon Inc.
04:01am, Monday, 23'rd May 2022 GlobeNewswire Inc.
--Kala Will Receive $60 Million in Upfront Payment; Eligible to Receive Additional Sales-Based Milestone Payments----Kala Will Focus Resources on Phase 2/3 Trial of KPI-012 for Orphan Disease Persiste
What 4 Analyst Ratings Have To Say About Kala Pharmaceuticals
04:01pm, Tuesday, 17'th May 2022 Benzinga
Kala Pharmaceuticals (NASDAQ:KALA) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
1
0
1
0
Kala Pharmaceuticals (KALA) Reports Q1 Loss, Misses Revenue Estimates
12:15pm, Monday, 16'th May 2022 Zacks Investment Research
Kala Pharma (KALA) delivered earnings and revenue surprises of -25% and 55.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q1 2022 Results - Earnings Call Transcript
10:54am, Monday, 16'th May 2022
Kala Pharmaceuticals, Inc. (NASDAQ:KALA ) Q1 2022 Results Earnings Conference Call May 16, 2022 8:00 AM ET Company Participants Jill Steier - Executive Director, Investor Relations and Corporate Commu
Kala Pharmaceuticals (KALA) Reports Q1 Loss, Misses Revenue Estimates
09:47am, Monday, 16'th May 2022
Kala Pharma (KALA) delivered earnings and revenue surprises of -25% and 55.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
11:15am, Thursday, 12'th May 2022 Zacks Investment Research
Dare Bioscience, Inc. (DARE) delivered earnings and revenue surprises of 28.57% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Trevena (TRVN) Reports Q1 Loss, Lags Revenue Estimates
12:15pm, Wednesday, 11'th May 2022 Zacks Investment Research
Trevena (TRVN) delivered earnings and revenue surprises of -11.11% and 96.94%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Athenex (ATNX) Reports Q1 Loss, Tops Revenue Estimates
01:55pm, Tuesday, 10'th May 2022 Zacks Investment Research
Athenex (ATNX) delivered earnings and revenue surprises of -50% and 16.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Kala Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call
12:00pm, Monday, 09'th May 2022 GlobeNewswire Inc.
ARLINGTON, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization
Kala Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call
08:00am, Monday, 09'th May 2022
ARLINGTON, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of
10 Top Penny Stocks To Buy For Under $1 May 2022 Edition
10:58pm, Thursday, 05'th May 2022 PennyStocks
Top penny stocks under $1 to watch in May.
The post 10 Top Penny Stocks To Buy For Under $1 May 2022 Edition appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
10 Top Penny Stocks To Buy For Under $1 May 2022 Edition
06:58pm, Thursday, 05'th May 2022
Top penny stocks under $1 to watch in May. The post 10 Top Penny Stocks To Buy For Under $1 May 2022 Edition appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Kala Pharmaceuticals Posts KPI-012 Data In Healing Impaired Ocular Diseases
01:25pm, Monday, 02'nd May 2022
Kala Pharmaceuticals Inc (NASDAQ: KALA) reported data from a Phase 1b trial of KPI-012, a cell-free secretome therapy for severe ocular diseases driven by impaired healing. As previously disclose
